Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 46Sanofi-Aventis Canada Inc.
02 29Valeant Canada LP / Valeant Canada S.E.C.
01 151338344
02 201341206
03 62055948
04 22174338
05 182382387
06 142382549
01 8Felodipine | Ramipril
02 47Ramipril
03 20Ramipril | Hydrochlorothiazide
01 19Capsule
02 56Tablet
01 62011-11-26
02 152013-05-21
03 22015-08-30
04 202018-03-20
05 182020-08-25
06 142020-08-30
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2015-08-30
Date Granted : 2009-11-03
Brand Name : ALTACE PLUS FELODIPINE
Patent Number : 2174338
Filing Date : 1995-08-30
Strength per Unit : 5 mg / 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-08-30
Date Granted : 2009-11-03
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2015-08-30
Date Granted : 2009-11-03
Brand Name : ALTACE PLUS FELODIPINE
Patent Number : 2174338
Filing Date : 1995-08-30
Strength per Unit : 2.5 mg/ 2.5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-08-30
Date Granted : 2009-11-03
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 2.5 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 5 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 10 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 1.25 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Brand Name : ALTACE
Patent Number : 1338344
Filing Date : 1988-11-23
Strength per Unit : 1.25 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 2.50 mg per tablet
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Brand Name : ALTACE
Patent Number : 1338344
Filing Date : 1988-11-23
Strength per Unit : 2.50 mg per tablet
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-05-21
Date Granted : 1996-05-21
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
Brand Name : ALTACE
Patent Number : 1341206
Filing Date : 1981-10-20
Strength per Unit : 5.00 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-03-20
Date Granted : 2001-03-20
